Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1Lymphoid 1Classical hematology 1

Conditions

Leukemia 26Precursor Cell Lymphoblastic Leukemia-Lymphoma 24Lymphoma 22Leukemia, Myeloid, Acute 22Myelodysplastic Syndromes 21Breast Neoplasms 18Lymphoma, Non-Hodgkin 16Central Nervous System Neoplasms 14Burkitt Lymphoma 12Leukemia, Myelogenous, Chronic, BCR-ABL Positive 11Leukemia, Lymphocytic, Chronic, B-Cell 11Multiple Myeloma 10Leukemia, Myeloid, Accelerated Phase 10Hodgkin Disease 10Dendritic Cell Sarcoma, Interdigitating 10Lymphoma, Large-Cell, Immunoblastic 9Lymphoma, Large B-Cell, Diffuse 9Lymphoma, Follicular 9Leukemia, Myeloid, Chronic-Phase 9Leukemia, Biphenotypic, Acute 9Brain Neoplasms 9Blast Crisis 9Neuroblastoma 8Medulloblastoma 8Lymphoma, Mantle-Cell 8Recurrence 7Lymphoma, B-Cell, Marginal Zone 7Hematologic Neoplasms 7Ovarian Neoplasms 6Congenital Abnormalities 6

Interventions

fludarabine phosphate 1Whole-Body Irradiation 1Thiotepa 1Standard of Care 1Melphalan 1Cyclophosphamide 1Busulfan 1Antilymphocyte Serum 1Alemtuzumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Metabolism, Inborn Errors × Thiotepa × Clear all
NCT01049854 2018-08-21

CD34+Selection for Partially Matched Family or Matched Unrelated Adult Donor Transplant

New York Medical College

Phase 2 Completed
20 enrolled
Classical hematologyLymphoidMyeloidOther hematologic neoplasm

Bone Marrow Failure Disorders, Anemia, Sickle Cell, Immunologic Deficiency Syndromes, Leukemia, Lymphoma, Metabolism, Inborn Errors, Histiocytosis, beta-Thalassemia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡